Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mi…
What to know about CRL
Charles River Laboratories International, Inc. is a Healthcare company with a mixed financial profile. It scores well on valuation and cash flow, but size is worth keeping an eye on.
Should you consider CRL?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Charles River Laboratories International, Inc. is a Healthcare company with a mixed overall financial profile — it ranks near the bottom of Healthcare stocks (54 of 59).
-
Profit margins are thin compared to most S&P 500 peers — the company keeps less of each dollar it earns than the average. Watch for signs of margin improvement.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
The stock is more volatile than most S&P 500 names — it can swing sharply in both directions. This suits investors comfortable with bigger short-term moves.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Healthcare sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how CRL compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | — | N/A |
| Forward P/E | 15.03 | Above avg |
| PEG Ratio | 0.12 | Top 25% |
| Price to Sales | 2.21 | Above avg |
| Price to Book | 3.03 | Above avg |
| EV/EBITDA | 13.29 | Above avg |
| Earnings Yield | — | N/A |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 34.46% | Average |
| Operating Margin | 15.92% | Average |
| Net Profit Margin | -4.58% | Below avg |
| Return on Equity | -5.87% | Below avg |
| Return on Invested Capital | 4.26% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 1.20% | Below avg |
| Revenue Growth (3Y CAGR) | 0.33% | Below avg |
| EPS Growth (YoY) | — | N/A |
| Free Cash Flow Growth | 3.37% | Average |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.36 | Above avg |
| Debt to Equity | 1.03 | Average |
| Interest Coverage | 0.07 | Below avg |
| Altman Z-Score | 2.26 | Average |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | — | N/A |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 4.39% | Above avg |
| OCF to Sales | — | N/A |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 1.45 | Below avg |
| Volatility (30-Day) | 50.04% | Below avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 9.34% | Below avg |
| Avg. Analyst Rating | 1.71 | Above avg |
| Target Upside % | 14.74% | Above avg |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 8.91B | Below avg |
How does CRL compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to CRL — based on their financial profile.